Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (8)

2020

  1. Autoimmune haemolytic anaemias: A retrospective study of 93 patients

    Medicina Clinica, Vol. 154, Núm. 9, pp. 331-337

  2. Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients

    Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671

  3. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

    Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268

  4. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk

    Leukemia, Vol. 34, Núm. 10, pp. 2648-2659

2015

  1. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications

    Annals of Hematology, Vol. 94, Núm. 5, pp. 779-787

  2. Trisomy 8, a cytogenetic abnormality in myelodysplastic syndromes, is constitutional or not?

    PLoS ONE, Vol. 10, Núm. 6

2014

  1. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    British Journal of Haematology, Vol. 166, Núm. 2, pp. 189-201

2012

  1. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants

    American Journal of Kidney Diseases, Vol. 59, Núm. 5, pp. 707-710